Can azithromycin (Z‑Pack) be taken together with amoxicillin‑clavulanate (Augmentin)?

Can You Take Z-Pack and Augmentin Together?

No, you should not routinely take azithromycin (Z-Pack) and amoxicillin-clavulanate (Augmentin) together for common infections. These antibiotics are typically used as alternatives to each other, not in combination, and there is no established clinical benefit to using both simultaneously for standard respiratory or other common bacterial infections.

Why These Are Not Combined

Different Mechanisms and Overlapping Coverage

• Azithromycin is a macrolide antibiotic that covers atypical bacteria (Mycoplasma, Chlamydophila) and some typical respiratory pathogens
• Amoxicillin-clavulanate is a beta-lactam/beta-lactamase inhibitor combination that primarily targets typical bacterial pathogens (Streptococcus pneumoniae, Haemophilus influenzae)
• For most infections, one agent is sufficient and appropriate based on the suspected pathogen

Guideline Recommendations Show Sequential, Not Concurrent Use

For respiratory infections, guidelines consistently recommend these as alternative options or switch therapy, never as combination therapy:

• For acute bacterial rhinosinusitis, amoxicillin-clavulanate is first-line for mild disease, while azithromycin is reserved for beta-lactam allergic patients 1
• For community-acquired pneumonia in children, guidelines recommend adding a macrolide to a beta-lactam only when atypical pneumonia cannot be distinguished from bacterial pneumonia—but this means choosing one beta-lactam plus one macrolide based on clinical presentation, not routinely combining both 2
• For adult CAP, combination therapy means amoxicillin-clavulanate plus a macrolide (like azithromycin) for patients with comorbidities, but this is a specific therapeutic strategy for coverage of both typical and atypical pathogens 3

When Combination Beta-Lactam/Macrolide Therapy IS Appropriate

The only scenario where combining a beta-lactam with a macrolide makes clinical sense is:

Community-Acquired Pneumonia with Specific Risk Factors

• Adults with comorbidities (chronic heart/lung/liver/renal disease, diabetes, alcoholism, malignancy, asplenia): Amoxicillin-clavulanate 875/125 mg twice daily plus azithromycin 500 mg day 1, then 250 mg daily for 4 days 3
• Children ≥5 years when bacterial vs. atypical pneumonia cannot be distinguished: Amoxicillin plus azithromycin 2
• Hospitalized patients with moderate-to-severe CAP: Beta-lactam (ceftriaxone or cefotaxime) plus azithromycin 4, 2

This combination provides coverage for both typical bacteria (S. pneumoniae, H. influenzae) and atypical pathogens (Mycoplasma, Chlamydophila, Legionella).

Common Clinical Scenarios

Acute Otitis Media

• Use either high-dose amoxicillin-clavulanate (90 mg/kg/day) or azithromycin, not both 5, 6, 7
• Amoxicillin-clavulanate is superior for bacterial eradication, especially for penicillin-resistant S. pneumoniae and beta-lactamase-producing H. influenzae 7

Acute Bacterial Sinusitis

• First-line: Amoxicillin-clavulanate (high-dose: 4 g/250 mg daily for adults) 1
• Alternative for beta-lactam allergy: Azithromycin 1
• Switch therapy (not combination): If no improvement after 72 hours on one agent, switch to the other or a fluoroquinolone 1

Bronchiectasis Exacerbations

• Azithromycin is non-inferior to amoxicillin-clavulanate for resolution by 21 days, though exacerbations resolve faster with amoxicillin-clavulanate 8
• Use one or the other, not both

Safety Considerations

Drug Interactions and Adverse Events

• No specific dangerous interaction between azithromycin and amoxicillin-clavulanate exists
• However, combining antibiotics unnecessarily:
  • Increases risk of adverse events (diarrhea, GI upset more common with amoxicillin-clavulanate; azithromycin has QT prolongation risk) 9, 10
  • Promotes antibiotic resistance
  • Provides no additional clinical benefit for most infections

QT Prolongation Risk

• Azithromycin carries cardiovascular risk, particularly when combined with other QT-prolonging medications 10
• Avoid azithromycin in patients already taking QT-prolonging drugs

Bottom Line Algorithm

Should you take both together?

1. For uncomplicated respiratory infections (sinusitis, otitis media, simple pneumonia): No - choose one based on severity, recent antibiotic use, and allergies
2. For CAP with comorbidities or moderate-to-severe disease: Yes - this is appropriate combination therapy for dual coverage
3. For treatment failure: No - switch from one to the other, don't add the second
4. For beta-lactam allergy: No - use azithromycin alone (or a fluoroquinolone for severe cases)

If a physician has prescribed both simultaneously for a simple infection, clarify the indication. This is not standard practice and may represent either an error or a specific clinical scenario (like hospitalized pneumonia) that warrants combination therapy.